Overview

A Study of Xenical (Orlistat) in Overweight and Obese Adolescents

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
This 2 arm study will assess the effect of Xenical on body mass index (BMI)in obese or overweight adolescents. Patients will be randomised into one of 2 groups; both groups will undergo a regimen of mildly hypocaloric diet and physical exercise, but one group will also receive Xenical 120mg po tid. The anticipated time on study treatment is 1 year, and the target sample size is <100 individuals.
Phase:
Phase 3
Details
Lead Sponsor:
Hoffmann-La Roche
Treatments:
Orlistat